Neuroleptic and Huntington disease. Comparison of olanzapine, tetrabenazine and tiapride. A multicentric, randomised, controlled study.
Phase of Trial: Phase III
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Olanzapine (Primary) ; Tetrabenazine (Primary) ; Tiapride (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- Acronyms NEUROHD
- 18 Jan 2018 Status changed from recruiting to completed.
- 30 Jul 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.
- 30 Jul 2015 Planned end date changed from 1 Mar 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov.